Ionis Pharmaceuticals, Inc. (IONS)
NASDAQ: IONS · Real-Time Price · USD
81.80
+2.61 (3.30%)
At close: Jul 2, 2026, 4:00 PM EDT
81.78
-0.02 (-0.02%)
After-hours: Jul 2, 2026, 7:53 PM EDT
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,402 employees as of December 31, 2025. The number of employees increased by 333 or 31.15% compared to the previous year.
Employees
1,402
Change (1Y)
333
Growth (1Y)
31.15%
Revenue / Employee
$754,772
Profits / Employee
-$233,222
Market Cap
13.52B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 1,402 | 333 | 31.15% |
| Dec 31, 2024 | 1,069 | 142 | 15.32% |
| Dec 31, 2023 | 927 | 131 | 16.46% |
| Dec 31, 2022 | 796 | 136 | 20.61% |
| Dec 31, 2021 | 660 | -97 | -12.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| BioMarin Pharmaceutical | 3,221 |
| Bio-Techne | 3,100 |
| Jazz Pharmaceuticals | 2,890 |
| Axsome Therapeutics | 1,220 |
| Exelixis | 1,077 |
| Madrigal Pharmaceuticals | 915 |
| BridgeBio Pharma | 839 |
| Arrowhead Pharmaceuticals | 711 |
IONS News
- 7 days ago - Ionis Pharmaceuticals price target raised to $130 from $125 at H.C. Wainwright - TheFly
- 7 days ago - Ionis Pharmaceuticals enters zilganersen license agreement with Recordati - TheFly
- 7 days ago - Ionis announces license agreement with Recordati for zilganersen in Alexander disease (AxD) in all countries outside the U.S. - Business Wire
- 8 days ago - Ionis Pharmaceuticals price target raised to $75 from $74 at Goldman Sachs - TheFly
- 8 days ago - Ionis Pharmaceuticals Transcript: FDA announcement - Transcripts
- 8 days ago - Ionis Pharmaceuticals Slides: FDA announcement - Filings
- 8 days ago - Ionis Pharmaceuticals Press release: FDA announcement - Filings
- 8 days ago - FDA approves Ionis’ Tryngolza as adjunct to diet to reduce triglycerides - TheFly